Homocysteine induces ferroptosis in cardiomyocytes by disrupting β-catenin/GPX4 pathway

Yanping Lei1, Rui Liu2, Lewu Xu2

  • 1Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical College, University of South China, Hengyang, Hunan, China.

Plos One
|August 6, 2025
PubMed

Insights

Homocysteine damages heart cells by disrupting beta-catenin signaling, leading to reduced GPX4 expression and ferroptosis. Restoring beta-catenin protects against this homocysteine-induced cardiac injury.

Area of Science:

  • Cardiology
  • Cell Biology
  • Biochemistry

Background:

  • Homocysteine is known to damage cardiomyocytes, but the precise mechanism remains unclear.
  • Ferroptosis, a regulated cell death pathway, plays a significant role in the development and progression of cardiac diseases.

Purpose of the Study:

  • To investigate the role of beta-catenin/GPX4 signaling in homocysteine-induced ferroptosis of cardiomyocytes.
  • To elucidate the molecular mechanisms by which homocysteine affects cardiac cells.

Main Methods:

  • Established a hyperhomocysteinemia mouse model and treated with deferoxamine (DFO) or ferrostatin-1 (Fer-1).
  • Assessed protein expression (beta-catenin, GPX4), lipid reactive oxygen species (ROS), iron, glutathione, cell viability, and mitochondrial morphology.
  • Utilized chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays to determine the interaction between beta-catenin and the GPX4 promoter.

Main Results:

  • Homocysteine inhibited beta-catenin activity and GPX4 expression, promoting ferroptosis in cardiomyocytes both in vitro and in vivo.
  • Overexpression of beta-catenin increased GPX4 expression, thereby inhibiting homocysteine-induced ferroptosis.
  • GPX4 was identified as a direct target gene of beta-catenin.

Conclusions:

  • Homocysteine induces ferroptosis in cardiomyocytes by impairing beta-catenin signaling.
  • This disruption leads to the downregulation of GPX4, a key regulator of ferroptosis, contributing to cardiac damage.
Abstract